“Receptor”的搜索结果，显示 121-130 项，共有 3155 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with ...

3. Primary mediastinal large B-cell lymphoma - 诊断与治疗- 妙佑医疗国际

   Chimeric antigen receptor (CAR)-T cell therapy trains the immune system cells to fight lymphoma cells. This treatment begins with removing some white blood ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...